| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC TWF1 STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 TAF1 | 4.99e-07 | 600 | 104 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC TRRAP TWF1 STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 TAF1 | 2.06e-06 | 764 | 104 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC TWF1 STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 TAF1 | 3.94e-06 | 709 | 104 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 TNIK CAMK1D HIPK4 POLB MKNK2 CAMK1 TEC TRRAP TWF1 STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 TAF1 | 6.66e-06 | 938 | 104 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 1.11e-05 | 27 | 104 | 4 | GO:0004683 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.00e-05 | 363 | 104 | 10 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TNIK CAMK1D HIPK4 MKNK2 CAMK1 STK4 CAMKV PRKAA2 SRPK3 DCLK2 TAF1 | 2.11e-05 | 446 | 104 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity | 8.03e-05 | 3 | 104 | 2 | GO:0008109 | |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 3.98e-04 | 6 | 104 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | chromatin binding | ATRX CHAF1A ADNP GRHL2 PPARGC1A GRHL1 NFKB1 PRKAA2 TAF1 STAG3 TOP2B HELLS | 4.63e-04 | 739 | 104 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 9.74e-04 | 145 | 104 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.30e-03 | 230 | 104 | 6 | GO:0005516 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 2.54e-05 | 307 | 104 | 9 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 3.43e-05 | 319 | 104 | 9 | GO:0018209 | |
| Domain | Protein_kinase_ATP_BS | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC STK4 FRK PRKAA2 SRPK3 DCLK2 | 1.07e-06 | 379 | 102 | 12 | IPR017441 |
| Domain | Kinase-like_dom | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC TRRAP STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 | 1.45e-06 | 542 | 102 | 14 | IPR011009 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.08e-06 | 69 | 102 | 6 | IPR020636 | |
| Domain | Prot_kinase_dom | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 | 2.59e-06 | 489 | 102 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC STK4 FRK CAMKV PRKAA2 SRPK3 DCLK2 | 2.84e-06 | 493 | 102 | 13 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | EPHB2 TNIK CAMK1D HIPK4 MKNK2 CAMK1 TEC STK4 FRK PRKAA2 SRPK3 DCLK2 | 7.68e-06 | 459 | 102 | 12 | PS00107 |
| Domain | Glyco_trans_14 | 8.68e-06 | 8 | 102 | 3 | IPR003406 | |
| Domain | Branch | 8.68e-06 | 8 | 102 | 3 | PF02485 | |
| Domain | S_TKc | 2.70e-05 | 359 | 102 | 10 | SM00220 | |
| Domain | Pkinase | 4.46e-05 | 381 | 102 | 10 | PF00069 | |
| Domain | Rhs_assc_core | 8.83e-05 | 3 | 102 | 2 | IPR022385 | |
| Domain | Ser/Thr_kinase_AS | 1.48e-04 | 357 | 102 | 9 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 1.64e-04 | 362 | 102 | 9 | PS00108 | |
| Domain | Tox-GHH_dom | 1.76e-04 | 4 | 102 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.76e-04 | 4 | 102 | 2 | PF15636 | |
| Domain | Ten_N | 1.76e-04 | 4 | 102 | 2 | IPR009471 | |
| Domain | Ten_N | 1.76e-04 | 4 | 102 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.76e-04 | 4 | 102 | 2 | PS51361 | |
| Domain | SH3_1 | 2.81e-04 | 164 | 102 | 6 | PF00018 | |
| Domain | YD | 2.92e-04 | 5 | 102 | 2 | IPR006530 | |
| Domain | CP2 | 4.37e-04 | 6 | 102 | 2 | PF04516 | |
| Domain | CP2 | 4.37e-04 | 6 | 102 | 2 | IPR007604 | |
| Domain | DUF1220 | 1.04e-03 | 9 | 102 | 2 | SM01148 | |
| Domain | SH3 | 1.20e-03 | 216 | 102 | 6 | SM00326 | |
| Domain | SH3 | 1.20e-03 | 216 | 102 | 6 | PS50002 | |
| Domain | Na_channel_asu | 1.29e-03 | 10 | 102 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.29e-03 | 10 | 102 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.29e-03 | 10 | 102 | 2 | PF06512 | |
| Domain | SH3_domain | 1.31e-03 | 220 | 102 | 6 | IPR001452 | |
| Domain | DUF1220 | 1.57e-03 | 11 | 102 | 2 | PF06758 | |
| Domain | NBPF_dom | 1.57e-03 | 11 | 102 | 2 | IPR010630 | |
| Domain | NBPF | 1.57e-03 | 11 | 102 | 2 | PS51316 | |
| Domain | NHL | 2.22e-03 | 13 | 102 | 2 | PS51125 | |
| Domain | CarboxyPept-like_regulatory | 3.81e-03 | 17 | 102 | 2 | IPR008969 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | FLII ATRX POLB CHAF1A ADNP INTS3 TRRAP BRD9 TAF1 SNX9 TOP2B HELLS | 1.09e-07 | 533 | 108 | 12 | 30554943 |
| Pubmed | TNIK PEG3 SORBS1 TENM2 STRIP1 TENM3 SUGP2 SIPA1L1 MTCL1 USP15 | 6.03e-07 | 407 | 108 | 10 | 12693553 | |
| Pubmed | 2.26e-06 | 272 | 108 | 8 | 31010829 | ||
| Pubmed | FLII NDST1 KDM5B ITCH ATRX CORO2A PEG3 SORBS1 CAMK1 CFAP298 OTOF FEZ1 SIPA1L1 DCLK2 TAF1 REPS2 | 2.29e-06 | 1285 | 108 | 16 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B ITCH HIPK4 SORBS1 TWF1 STK4 SIPA1L1 ARFGAP1 PRKAA2 ASS1 SRPK3 DCLK2 MTCL1 | 2.83e-06 | 861 | 108 | 13 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLII STRN3 ATRX CHAF1A YTHDC2 INTS3 TRRAP STRIP1 SUGP2 SIPA1L1 ARFGAP1 TOP2B | 5.37e-06 | 774 | 108 | 12 | 15302935 |
| Pubmed | Phosphatidylinositol 4-kinase IIα function at endosomes is regulated by the ubiquitin ligase Itch. | 8.14e-06 | 13 | 108 | 3 | 23146885 | |
| Pubmed | TNIK FLII STRN3 ITCH GRIA1 SORBS1 ADNP TENM2 STRIP1 TWF1 CAMKV SIPA1L1 MTCL1 | 9.44e-06 | 963 | 108 | 13 | 28671696 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28973039 | ||
| Pubmed | NF-κB p65 Attenuates Cardiomyocyte PGC-1α Expression in Hypoxia. | 9.55e-06 | 2 | 108 | 2 | 35883637 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18974883 | ||
| Pubmed | Inhibiting PDGF-D alleviates the symptoms of HELLP by suppressing NF-κB activation. | 9.55e-06 | 2 | 108 | 2 | 33640869 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23831825 | ||
| Pubmed | Structural basis of gene regulation by the Grainyhead/CP2 transcription factor family. | 9.55e-06 | 2 | 108 | 2 | 29309642 | |
| Pubmed | NF-kappaB regulates the transcription of protein tyrosine kinase Tec. | 9.55e-06 | 2 | 108 | 2 | 19843184 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.43e-05 | 167 | 108 | 6 | 20362541 | |
| Pubmed | 1.64e-05 | 469 | 108 | 9 | 27634302 | ||
| Pubmed | 1.92e-05 | 17 | 108 | 3 | 29299163 | ||
| Pubmed | Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. | 2.29e-05 | 53 | 108 | 4 | 7774911 | |
| Pubmed | 2.85e-05 | 56 | 108 | 4 | 22745667 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17173071 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 24375798 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12175488 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12393799 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26365797 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12549979 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28344757 | ||
| Pubmed | Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling. | 2.86e-05 | 3 | 108 | 2 | 23563317 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28714958 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26069269 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 32457312 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 34326699 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23223635 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 16831572 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK STRN3 ATRX YTHDC2 ADNP TWF1 STK4 SUGP2 ARFGAP1 SNX9 TOP2B HELLS | 3.45e-05 | 934 | 108 | 12 | 33916271 |
| Pubmed | 3.72e-05 | 21 | 108 | 3 | 16079250 | ||
| Pubmed | 4.03e-05 | 405 | 108 | 8 | 38187761 | ||
| Pubmed | 5.70e-05 | 686 | 108 | 10 | 29987050 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8754826 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 5.71e-05 | 4 | 108 | 2 | 10225957 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20404331 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 24133254 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 35013237 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 33199366 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 17056143 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12935886 | ||
| Pubmed | Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling. | 5.71e-05 | 4 | 108 | 2 | 22507528 | |
| Pubmed | MST1 modulates Th17 activation in psoriasis via regulating TLR4-NF-κB pathway. | 5.71e-05 | 4 | 108 | 2 | 32930944 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 32243780 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 5.71e-05 | 4 | 108 | 2 | 12000766 | |
| Pubmed | 6.13e-05 | 430 | 108 | 8 | 32581705 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | HIPK4 NOP16 POLB MKNK2 CAMK1 NEB SUGP2 SIPA1L1 SRPK3 NSMCE4A | 6.35e-05 | 695 | 108 | 10 | 23602568 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.69e-05 | 220 | 108 | 6 | 35785414 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.19e-05 | 440 | 108 | 8 | 34244565 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TNIK STRN3 PKD1L1 HAUS3 SORBS1 PHAF1 SIPA1L1 NFKB1 ARFGAP1 SNX9 USP15 | 7.20e-05 | 853 | 108 | 11 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ALLC RBBP5 CHAF1A ADNP INTS3 TRRAP SUGP2 NFKB1 SNX9 TOP2B HELLS | 7.51e-05 | 857 | 108 | 11 | 25609649 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 8.90e-05 | 724 | 108 | 10 | 36232890 | |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 9.02e-05 | 28 | 108 | 3 | 24462114 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 32589942 | ||
| Pubmed | Cryo-EM structure of the Hippo signaling integrator human STRIPAK. | 9.50e-05 | 5 | 108 | 2 | 33633399 | |
| Pubmed | Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling. | 9.50e-05 | 5 | 108 | 2 | 30622739 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 18674809 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 37660994 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 17724025 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 17785586 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 34048454 | ||
| Pubmed | CCM-3/STRIPAK promotes seamless tube extension through endocytic recycling. | 9.50e-05 | 5 | 108 | 2 | 25743393 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.21e-04 | 608 | 108 | 9 | 36089195 | |
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 1.35e-04 | 32 | 108 | 3 | 7542761 | |
| Pubmed | 1.38e-04 | 251 | 108 | 6 | 28077445 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 20491914 | ||
| Pubmed | Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis. | 1.42e-04 | 6 | 108 | 2 | 36050503 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 26926143 | ||
| Pubmed | STRIPAK components determine mode of cancer cell migration and metastasis. | 1.42e-04 | 6 | 108 | 2 | 25531779 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 16684769 | ||
| Pubmed | Activation of Mevalonate Pathway via LKB1 Is Essential for Stability of Treg Cells. | 1.42e-04 | 6 | 108 | 2 | 31167140 | |
| Pubmed | 1.54e-04 | 86 | 108 | 4 | 37253089 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.67e-04 | 372 | 108 | 7 | 22939624 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 27907249 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 15870106 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 10625539 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 12915301 | ||
| Pubmed | TNIK FLII STRN3 GRIA1 SORBS1 TENM2 SUGP2 CAMKV SIPA1L1 ARFGAP1 DCLK2 USP15 | 2.23e-04 | 1139 | 108 | 12 | 36417873 | |
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | 2.27e-04 | 38 | 108 | 3 | 11555636 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.63e-04 | 283 | 108 | 6 | 30585729 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 10331952 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 21118569 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 24371122 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 11264466 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.76e-04 | 536 | 108 | 8 | 15840001 | |
| Pubmed | 2.83e-04 | 538 | 108 | 8 | 10512203 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM5B STRN3 ITCH YTHDC2 TRRAP STRIP1 FARS2 SIPA1L1 KLHL15 MTCL1 USP15 | 2.99e-04 | 1005 | 108 | 11 | 19615732 |
| Pubmed | 3.06e-04 | 689 | 108 | 9 | 36543142 | ||
| Pubmed | ATRX RBBP5 CHAF1A ADNP TRRAP SUGP2 ASS1 BRD9 TAF1 TOP2B HELLS | 3.22e-04 | 1014 | 108 | 11 | 32416067 | |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 3.30e-04 | 105 | 108 | 4 | 19156129 | |
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 16382098 | ||
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 24930734 | ||
| Pubmed | TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. | 3.39e-04 | 9 | 108 | 2 | 15899866 | |
| Pubmed | Random mutagenesis of proximal mouse chromosome 5 uncovers predominantly embryonic lethal mutations. | 3.39e-04 | 9 | 108 | 2 | 16024820 | |
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 19531582 | ||
| Interaction | STK3 interactions | 4.81e-06 | 181 | 105 | 8 | int:STK3 | |
| Interaction | SMARCC2 interactions | 1.58e-05 | 353 | 105 | 10 | int:SMARCC2 | |
| Cytoband | 1p13.3 | 6.85e-07 | 69 | 109 | 5 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 1.55e-04 | 211 | 109 | 5 | chr1p13 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 2.57e-06 | 8 | 66 | 3 | 441 | |
| GeneFamily | Neuroblastoma breakpoint family | 7.81e-05 | 23 | 66 | 3 | 662 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.65e-04 | 9 | 66 | 2 | 1203 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.39e-03 | 20 | 66 | 2 | 1371 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 6.63e-06 | 174 | 105 | 7 | M45676 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 KDM5B STRN3 ITCH ATRX ADNP TRRAP FAT1 FARS2 SIPA1L1 NFKB1 MTCL1 USP15 SKAP2 | 8.25e-06 | 856 | 105 | 14 | M4500 |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 1.59e-05 | 199 | 105 | 7 | M7374 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_DN | 1.64e-05 | 200 | 105 | 7 | M8763 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ATRX PEG3 GRIA1 SLC6A15 SORBS1 NEB TENM2 STRIP1 ZNF248 PPARGC1A SUGP2 PRKAA2 SCN8A DCLK2 SARDH | 3.46e-05 | 1106 | 105 | 15 | M39071 |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-08 | 191 | 109 | 8 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-07 | 164 | 109 | 7 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-07 | 164 | 109 | 7 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.99e-07 | 187 | 109 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.07e-06 | 163 | 109 | 6 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.97e-06 | 183 | 109 | 6 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.97e-06 | 183 | 109 | 6 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.35e-06 | 185 | 109 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 6.55e-06 | 186 | 109 | 6 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 187 | 109 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.40e-06 | 190 | 109 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.58e-06 | 195 | 109 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 8.58e-06 | 195 | 109 | 6 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.09e-06 | 197 | 109 | 6 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.36e-06 | 198 | 109 | 6 | 326e97bdc27cc3440f5488c2519446580cdc9d51 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.36e-06 | 198 | 109 | 6 | 2fdb92b198ba24e326e90479fd024400d956fb32 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.18e-05 | 170 | 109 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 71c90c57225e452c73bf7bea46b454c472bf5f76 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.89e-05 | 174 | 109 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.08e-05 | 175 | 109 | 5 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.08e-05 | 175 | 109 | 5 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 176 | 109 | 5 | 35610e7ac9902687e222641202409bab279c3998 | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 7.28e-05 | 176 | 109 | 5 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.47e-05 | 177 | 109 | 5 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.09e-05 | 180 | 109 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 8.52e-05 | 182 | 109 | 5 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.97e-05 | 184 | 109 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.44e-05 | 186 | 109 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.68e-05 | 187 | 109 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 9.93e-05 | 188 | 109 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 9.93e-05 | 188 | 109 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.02e-04 | 189 | 109 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 189 | 109 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.02e-04 | 189 | 109 | 5 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 189 | 109 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 190 | 109 | 5 | e59e3ad044af7b4409d5ecbd326fe83862e5fc9a | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.04e-04 | 190 | 109 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 190 | 109 | 5 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.04e-04 | 190 | 109 | 5 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 1.04e-04 | 190 | 109 | 5 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 1.04e-04 | 190 | 109 | 5 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.07e-04 | 191 | 109 | 5 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.07e-04 | 191 | 109 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.10e-04 | 192 | 109 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-04 | 192 | 109 | 5 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 192 | 109 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 192 | 109 | 5 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 193 | 109 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 193 | 109 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.12e-04 | 193 | 109 | 5 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 193 | 109 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 193 | 109 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 193 | 109 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.15e-04 | 194 | 109 | 5 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 194 | 109 | 5 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 197 | 109 | 5 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 197 | 109 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.24e-04 | 197 | 109 | 5 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-04 | 197 | 109 | 5 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 197 | 109 | 5 | a902aa05e5f711bcfdd9e19749ab636b597eb116 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 198 | 109 | 5 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 198 | 109 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 198 | 109 | 5 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-04 | 199 | 109 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 109 | 5 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 200 | 109 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 2.30e-04 | 122 | 109 | 4 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | COVID-19_Mild-immature_Neutrophil|COVID-19_Mild / Disease condition and Cell class | 2.37e-04 | 123 | 109 | 4 | a6670825fd8d9f9a0111a7b68598c764c99abb0d | |
| ToppCell | COVID-19_Mild-immature_Neutrophil-|COVID-19_Mild / Disease condition and Cell class | 2.37e-04 | 123 | 109 | 4 | 5f19b0e32509bedeb9ac6c74ac7a20750798da5e | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.20e-06 | 195 | 104 | 8 | 3710_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.45e-06 | 197 | 104 | 8 | 1518_DN | |
| Drug | Nem-S-G | 5.10e-06 | 8 | 104 | 3 | CID000126950 | |
| Disease | autosomal dominant nonsyndromic deafness (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0050564 (implicated_via_orthology) | |
| Disease | high grade glioma (is_implicated_in) | 1.65e-05 | 42 | 107 | 4 | DOID:3070 (is_implicated_in) | |
| Disease | social interaction measurement | 2.42e-05 | 94 | 107 | 5 | EFO_0009592 | |
| Disease | tyrosine-protein kinase TEC measurement | 7.78e-05 | 4 | 107 | 2 | EFO_0020830 | |
| Disease | Borderline personality disorder | 2.79e-04 | 35 | 107 | 3 | HP_0012076 | |
| Disease | Myopathies, Nemaline | 3.60e-04 | 8 | 107 | 2 | C0206157 | |
| Disease | cortical surface area measurement | TNIK BNC2 STRN3 ITCH RBBP5 CHAF1A RASGEF1A SLC6A15 HMGCR TENM2 STRIP1 NFKB1 PDGFD MTCL1 | 3.62e-04 | 1345 | 107 | 14 | EFO_0010736 |
| Disease | myositis | 3.85e-04 | 39 | 107 | 3 | EFO_0000783 | |
| Disease | pyoderma gangrenosum | 4.61e-04 | 9 | 107 | 2 | EFO_0006835 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.75e-04 | 10 | 107 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.75e-04 | 10 | 107 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | cholate measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0021509 | |
| Disease | glycerophosphorylcholine measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0020018 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 8.40e-04 | 12 | 107 | 2 | C0270960 | |
| Disease | nervous system disorder | 9.52e-04 | 53 | 107 | 3 | C0027765 | |
| Disease | age at first birth measurement | 9.72e-04 | 120 | 107 | 4 | EFO_0009101 | |
| Disease | obesity (implicated_via_orthology) | 1.14e-03 | 215 | 107 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.24e-03 | 447 | 107 | 7 | C3714756 | |
| Disease | respiratory symptom change measurement, response to placebo | 1.71e-03 | 17 | 107 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 1.92e-03 | 18 | 107 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | Hereditary hearing loss and deafness | 2.00e-03 | 146 | 107 | 4 | cv:C0236038 | |
| Disease | cystathionine measurement | 2.14e-03 | 19 | 107 | 2 | EFO_0010474 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.37e-03 | 20 | 107 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.59e-03 | 75 | 107 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | skin hydration measurement | 2.62e-03 | 21 | 107 | 2 | EFO_0009586 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.14e-03 | 23 | 107 | 2 | C1335177 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.54e-03 | 171 | 107 | 4 | DOID:9352 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FEPNDFYLKNTTWED | 41 | Q9H2P0 | |
| ELEAPETFSEEYLWK | 66 | Q7L0X2 | |
| SWAEAYKDLENSDEF | 296 | O60477 | |
| TAAAPVWEEAKIFYD | 21 | Q9BXI3 | |
| EWRSSYEDYADKPLE | 11 | Q9H8M2 | |
| FEAIAELKSDDWSYL | 121 | Q8N6M5 | |
| KSEDRLSEQDWPAYF | 16 | Q6ZN30 | |
| EWFKQDLPSYLFPED | 266 | P54646 | |
| LFDFTPKWRATYEDQ | 246 | A6NHR8 | |
| PDIDLDSENILWEYF | 1911 | Q7Z2Y8 | |
| DEKNWGLSFYADKPE | 136 | P19652 | |
| DKAFEDWLNDDLGSY | 161 | Q8N6T3 | |
| PWAQDTKLLDYEVDS | 586 | Q13111 | |
| DLSNYSEDEAWPSLF | 256 | Q8IWE4 | |
| ESWNFSQDYDPELIK | 411 | Q86XH1 | |
| EFIWPAIQSSALYED | 71 | P00966 | |
| DYSNPKWDETSLGFL | 311 | Q96M43 | |
| LFYDWLFFSPDKDSI | 396 | Q68E01 | |
| SPDDLKYIEEFNKSW | 1421 | Q9Y4B5 | |
| PSWDFDYDTKVVDLD | 4326 | Q14517 | |
| LPDVFDDLKSFESWF | 401 | Q9NRZ9 | |
| KPADRAAEWYNIDFS | 381 | Q13045 | |
| DAANPWQLKSSADYL | 256 | Q8NE63 | |
| LLSWSKDTYSPDEHF | 286 | Q8N0V5 | |
| KDTYSPDEHFWVTLN | 291 | Q8N0V5 | |
| WNYECPKFEEDVLSS | 46 | P04035 | |
| EFPAPYWDNITDSAK | 611 | Q8N568 | |
| YEADFDSATKTFPNW | 116 | P29323 | |
| EDLLKYFNPESWQED | 221 | Q9GZP0 | |
| SIQEGKYEFPDKDWA | 321 | Q9HBH9 | |
| DAGDDLLLSYVKEFW | 371 | P52848 | |
| SDSFVEDPWLSPKYD | 921 | Q0VF49 | |
| DASEPYNTAKAIAEW | 156 | O43766 | |
| ELFRKSDYLDWECPN | 151 | A0A087WXM9 | |
| EAPDYDRSQWLDVKF | 41 | P21266 | |
| DPFNNYSDEEIWKAL | 1396 | Q92887 | |
| WDALTDNYIPSLSED | 106 | Q99689 | |
| KLSPEEEEYLDSGWN | 446 | Q9UGL1 | |
| SEAEDWETPKPFYQL | 611 | C9JSJ3 | |
| WAPNLYELDSDLTKE | 16 | Q9GZU2 | |
| VENWSAFAPDFKELD | 326 | Q15291 | |
| EFDSPYWDDISDSAK | 236 | Q14012 | |
| FDDSEDESDKLSYPW | 511 | Q9UBK2 | |
| DLESIDPEFYNSLIW | 676 | Q96J02 | |
| PFDLSYKTVDQWEID | 216 | P42685 | |
| LEENDDDAYLNSPWA | 256 | P57076 | |
| SPAPDWYKDFVTDAD | 1996 | P46100 | |
| PTLDMALFDWTDYED | 226 | Q8NBI3 | |
| ALFDWTDYEDLKPDG | 231 | Q8NBI3 | |
| SEDEAWKSYLENPLT | 31 | Q6ISB3 | |
| YTSEDEAWKSFLENP | 26 | Q9NZI5 | |
| YSDSILTFDPDENKW | 556 | Q96M94 | |
| LWEEAAYDQSLPDFS | 101 | Q8WZ55 | |
| EFDSPYWDDISQAAK | 246 | Q8NCB2 | |
| VQDFFAWSKDTYSPD | 321 | Q9P109 | |
| QPYWAKLDDTSLEFL | 326 | Q9UKA2 | |
| LDVKWNPFDDFEIAS | 86 | Q92828 | |
| YPKADNLNGEDFDWL | 16 | Q68CZ6 | |
| YWNEDDKFVPAATDA | 381 | P42261 | |
| LQLKSEYPDLFEWFC | 106 | Q6UXH1 | |
| EEWYDQDKPEVSLLF | 501 | Q8WUM9 | |
| LPVDSEKDIFDYIQW | 311 | P06746 | |
| TPSDFLVKQIYFWDE | 1626 | Q8TDX9 | |
| YPKELESEFDNFEDW | 1411 | Q9HC10 | |
| TWPSEIASEDYDLLF | 421 | Q6S8J7 | |
| DEDWDGPKSSSYFKD | 166 | Q9Y5X1 | |
| SYDLPANKDAFRKTW | 456 | Q13033 | |
| AWIEDKASEEFLSYP | 601 | Q9H2J7 | |
| DFPAADLDSLWEDFS | 136 | Q8IYL2 | |
| YETWEKFDPDATQFI | 1621 | P35499 | |
| QELSFYSIPEFDEWK | 606 | Q02880 | |
| AGFSYEKWEINPSEL | 356 | P42680 | |
| SFLWIYHSKNPEVDD | 31 | Q4G0N0 | |
| DYSNPKWDETSLGFL | 311 | Q86XG9 | |
| DYSNPKWDETSLGFL | 311 | Q5VWK0 | |
| IYQFTAASPKDAEEW | 196 | O75563 | |
| DKPWYSIFPIDNEDL | 461 | P21675 | |
| ATRNSDFPVWDDYKS | 21 | Q15761 | |
| DFPVWDDYKSSVDDL | 26 | Q15761 | |
| FWDLLSSPYFTEDRK | 1796 | P58107 | |
| PDLEFEYADTDKWAA | 66 | Q5VSL9 | |
| DLDWSNLVDAAKAYE | 1676 | O43166 | |
| ASPNLAYTFIWDKTD | 1116 | Q9NT68 | |
| DSPDFEFIVYDSWKI | 186 | Q9NXX6 | |
| FSFQLDSWTEAPKYE | 136 | Q9BSU1 | |
| KRFYPAEWQDFLDSL | 156 | Q9Y3C1 | |
| DSPYWDDISDSAKDF | 241 | Q8IU85 | |
| KWETYFDHENTVDAP | 196 | Q96P63 | |
| YEANPIFWEEVSDKF | 331 | Q9UL12 | |
| EKYEWPLEQATQFSA | 526 | Q9UPE1 | |
| LLWSDPSEDYGNEKT | 226 | P48454 | |
| PDATYDFKSDLWSLG | 206 | Q9UKE5 | |
| LKEWTEAFPYDFQDE | 121 | Q8N9B8 | |
| PKWDCQLFDSYSESL | 376 | Q8NFH8 | |
| DEWLDSYKQDQDAGF | 116 | Q9UJ98 | |
| YELQIPSDEKLEEFW | 291 | Q9BX26 | |
| DLKNEPWYKFFSELE | 561 | Q9BX66 | |
| KEDPAYWFLSDENSL | 611 | Q8IX01 | |
| LDWDPDLKKRYFDEN | 751 | Q9Y4E8 | |
| ETFYEIWEKFDPDAT | 1786 | Q9UQD0 | |
| IWEKFDPDATQFIEY | 1791 | Q9UQD0 | |
| ASPNLAYTFIWDKTD | 1051 | Q9P273 | |
| DFLDNPEKWNTNYTL | 91 | Q5VVX9 | |
| LTEWYSAQENSFKPE | 411 | Q9H6S0 | |
| NSSDWKIPQDGDYEF | 421 | Q13043 | |
| DISFWLPSENYAEND | 366 | O95363 | |
| LKEWALHTFPNATDY | 3651 | Q9Y4A5 | |
| PALKAYWENTYDAAD | 531 | Q9H1B5 | |
| DFTQEEWYLLDPAQK | 16 | Q8NDW4 | |
| SDSWDKDYDSFVLPL | 46 | Q12792 | |
| LYTEDWEADKSLFYP | 206 | P20929 | |
| LVENFEPLYDLDDSW | 746 | P19838 |